Cardiovascular Drugs and Therapy

, Volume 16, Issue 4, pp 341–351 | Cite as

Intima Media Thickness as a Surrogate Marker for Generalised Atherosclerosis

  • Michiel L. Bots
  • D. Egbertus Grobbee


Vascular markers of atherosclerotic burden allow atherosclerosis to be studied in the sub-clinical phase of the disease, and facilitate the assessment of new therapies for modifying coronary heart disease (CHD) risk factors. B-mode ultrasound enables non-invasive, direct visualization of the arterial wall. The intima media thickness of the carotid artery (CIMT) quantified using this technique, is a reliable marker of atherosclerotic burden. Furthermore, it demonstrates greater sensitivity in detecting early atherosclerosis compared with angiography.

The validity of ultrasonographically-determined CIMT as a surrogate marker of atherosclerotic disease has been established; CIMT is positively associated with the incidence of coronary events, relates to atherosclerotic disease elsewhere in the arterial system and has common risk factors to the development of CHD. Furthermore, ultrasonographically-determined CIMT demonstrates good inter- and intra-observer reproducibility making it suitable for tracking the progression or regression of atherosclerotic disease over time.

The validity of CIMT as a vascular marker of atherosclerosis progression has been demonstrated in clinical trials. Intervention studies have shown that modification of CHD risk factors can significantly reduce progression of CIMT. Hence, B-mode ultrasonography is being used increasingly to elucidate the efficacy of new therapies, enabling the benefits of treatment to be established more rapidly and with fewer patients compared with clinical outcome trials.

intima media thickness B-mode ultrasound atherosclerosis progression coronary heart disease prevention lipid lowering statin therapy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Orloff DG. Use of surrogate endpoints: A practice necessity in lipid-altering and antiatherosclerosis drug development. Am J Cardiol 2001;87(suppl):35A–41A.Google Scholar
  2. 2.
    Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res 2001;89:305–316.Google Scholar
  3. 3.
    O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 2000;102:126–140.Google Scholar
  4. 4.
    Vliegenthart R, Oudkerk M, Song B, et al. Coronary calcification detected by electron-beam computed tomography and non-coronary measures of atherosclerosis: The Rotterdam Study. Circulation 2001;103:1344.Google Scholar
  5. 5.
    Arad Y, Newstein D, Cadet F, Roth M, Guerci AD. Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease in an electron-beam computed tomographic study. Arterioscler Thromb Vasc Biol 2001;21:2051–2058.Google Scholar
  6. 6.
    Newman AB, Naydeck BL, Sutton-Tyrrell K, Feldman A, Edmundowicz D, Kuller LH. Coronary artery calcification in older adults to age 99: Prevalence and risk factors. Circulation 2001;104:2679–2684.Google Scholar
  7. 7.
    Mahoney LT, Burns TL, Stanford W, et al. Usefulness of the Framingham risk score and body mass index to predict early coronary artery calcium in young adults (Muscatine Study). Am J Cardiol 2001;88:509–515.Google Scholar
  8. 8.
    Raggi P. The use of electron-beam computed tomography as a tool for primary prevention. Am J Cardiol 2001;88:28J–32J.Google Scholar
  9. 9.
    Vliegenthart R, Hollander M, Breteler MM, et al. Stroke is associated with coronary calcification as detected by electron-bean CT: The Rotterdam Coronary Calcification Study. Stroke 2002;33:462–465.Google Scholar
  10. 10.
    Callister TQ, Cooil B, Raya SP, Lippolis NJ, Russon DJ, Raggi P. Coronary artery disease: Improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 1998;208:807–814.Google Scholar
  11. 11.
    Prokop M. Multislice CT angiography. Eur J Radiol 2000;36:86–96.Google Scholar
  12. 12.
    Nieman K, Oudkerk M, Rensing BJ, et al. Coronary angiography with multi-slice computed tomography. Lancet 2001;357:599–603.Google Scholar
  13. 13.
    Achenbach S, Giesler T, Ropers D, et al. Detection of coronary artery stenoses by contrast-enhanced, retrospectively electrocardiographically-gated, multislice spiral computed tomography. Circulation 2001;103:2535–2538.Google Scholar
  14. 14.
    Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation 1986;74:1399–1406.Google Scholar
  15. 15.
    Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: Fundamental principles and description of a computerized analysing system. Clin Physiol 1991;11:565–577.Google Scholar
  16. 16.
    Persson J, Formgren J, Israelsson B, Berglund G. Ultrasound-determined intima-media thickness and atherosclerosis. Direct and indirect validation. Arterioscler Thromb 1994;14:261–264.Google Scholar
  17. 17.
    Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993;87(suppl II):II-56–II-65.Google Scholar
  18. 18.
    Wikstrand J, Wendelhag I. Methodological considerations of ultrasound investigation of intima-media thickness and lumen diameter. J Intern Med 1994;236:555–559.Google Scholar
  19. 19.
    Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation 1997;96:1432–1437.Google Scholar
  20. 20.
    Simon A, Gariepy J, Moyse D, Levenson J. Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes. Circulation 2001;103:2949–2954.Google Scholar
  21. 21.
    Furberg CD, Adams HP Jr, Applegate WB,et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation 1994;90:1679–1687.Google Scholar
  22. 22.
    Lonn E. Modifying the natural history of atherosclerosis: The SECURE trial. Int J Clin Pract Suppl 2001;13–18.Google Scholar
  23. 23.
    Pitt B, Byington RP, Furberg CD, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000;102:1503–1510.Google Scholar
  24. 24.
    Kanters SD, Algra A, van Leeuwen MS, Banga JD. Reproducibility of in vivo carotid intima-media thickness measurements: A review. Stroke 1997;28:665–671.Google Scholar
  25. 25.
    Tang R, Hennig M, Thomasson B, et al. Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: The European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2000;18:197–201.Google Scholar
  26. 26.
    Bots ML, Evans G, Riley W, et al. The osteoporosis prevention and arterial effects of tibolone (OPAL) study: Study design and baseline characteristics. Control Clin Trials 2001;22:85S.Google Scholar
  27. 27.
    Iglesias del Sol A, Bots ML, Grobbee DE, Hofman A, Witteman JC. Carotid intima-media thickness at different sites: Relation to incident myocardial infarction. The rotterdam study. Eur Heart J 2002;23:934–940.Google Scholar
  28. 28.
    Spá?il J, Češka R, Petrášek J, Šobra J. The effect of fouryear hypolipidaemic treatment on the intimal thickness of the common carotid artery in patients with familial hyperlipidaemia. Int Angiol 1999;18:313–319.Google Scholar
  29. 29.
    Mannami T, Konishi M, Baba S, Nishi N, Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese City: The Suita study. Stroke 1997;28:518–525.Google Scholar
  30. 30.
    Handa N, Matsumoto M, Maeda H, et al. Ultrasonic evaluation of early carotid atherosclerosis. Stroke 1990;21:1567–1572.Google Scholar
  31. 31.
    Hedblad B, Wikstrand J, Janzon L, Wedel H, Berglund G. Low-dose metroprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation 2001;103:1721–1726.Google Scholar
  32. 32.
    Polak JF, O'Leary DH, Kronmal RA, et al. Sonographic evaluation of carotid artery atherosclerosis in the elderly: Relationship of disease severity to stroke and transient ischemic attack. Radiology 1993;188:363–370.Google Scholar
  33. 33.
    Howard G, Sharrett AR, Heiss G, et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993;24:1297–1304.Google Scholar
  34. 34.
    Cuspidi C, Boselli L, Bragato R, et al. Echocardiographic and ultrasonographic evaluation of cardiac and vascular hypertrophy in patients with essential hypertension. Cardiology 1992;80:305–311.Google Scholar
  35. 35.
    Vaudo G, Schillaci G, Evangelista F, Pasqualini L, Verdecchia P, Mannarino E. Arterial wall thickening at different sites and its association with left ventricular hypertrophy in newly diagnosed essential hypertension.AmJ Hypertens 2000;13:324–331.Google Scholar
  36. 36.
    Crouse JR, Goldbourt U, Evans G, et al. Arterial enlargement in the atherosclerosis risk in communities (ARIC) cohort. In vivo quantification of carotid arterial enlargement. Stroke 1994;25:1354–1359.Google Scholar
  37. 37.
    Bots ML, Hofman A, Grobbee DE. Increased common carotid intima-media thickness. Adaptive response or a reflection of atherosclerosis? Findings from the Rotterdam Study. Stroke 1997;28:2442–2447.Google Scholar
  38. 38.
    Salonen R, Salonen JT. Determinants of carotid intima-media thickness:Apopulation-based ultrasonography study in eastern Finnish men. J Intern Med 1991;229:225–231.Google Scholar
  39. 39.
    Grobbee DE, Bots ML. Carotid artery intima-media thickness as an indicator of generalized atherosclerosis. J Intern Med 1994;236:567–573.Google Scholar
  40. 40.
    Howard G, O'Leary DH, Zaccaro D, et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996;93:1809–1817.Google Scholar
  41. 41.
    Markus RA, Mack WJ, Azen SP, Hodis HN. Influence of lifestyle modification on atherosclerotic progression determined by ultrasonographic change in the common carotid intima-media thickness.AmJ Clin Nutr 1997;65:1000–1004.Google Scholar
  42. 42.
    Bonithon-Kopp C, Coudray C, Berr C, et al. Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The EVA Study. Etude sur le Vieillisement Arteriel. Am J Clin Nutr 1997;65:121–127.Google Scholar
  43. 43.
    Kiechl S, Willeit J. The natural course of atherosclerosis. Part II: Vascular remodeling. Bruneck Study Group. Arterioscler Thromb Vasc Biol 1999;19:491–1498.Google Scholar
  44. 44.
    Psaty BM, Furberg CD, Kuller LH, et al. JAMA 1992;268:1287–1291.Google Scholar
  45. 45.
    Stensland-Bugge E, Bonaa KH, Joakimsen O, Njolstad I. Sex differences in the relationship of risk factors to subclinical carotid atherosclerosis measured 15 years later: The Tromso study. Stroke 2000;31:574–581.Google Scholar
  46. 46.
    Bots ML, Witteman JC, Grobbee DE. Carotid intima-media wall thickness in elderlywomenwith and without atherosclerosis of the abdominal aorta. Atherosclerosis 1993;102:99–105.Google Scholar
  47. 47.
    Bots ML, Hofman A, Grobbee DE. Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study. Arterioscler Thromb 1994;14:1885–1891.Google Scholar
  48. 48.
    Allan PL, Mowbray PI, Lee AJ, Fowkes FGR. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease. The Edinburgh Artery Study. Stroke 1997;28:348–353.Google Scholar
  49. 49.
    Mattace Raso F, Rosato M, Talerico A, Cotronei P, Mattace R. Intimal-medial thickness of the common carotid arteries and lower limbs atherosclerosis in the elderly. Minerva Cardioangiol 1999;47:321–327.Google Scholar
  50. 50.
    Davis PH, Dawson JD, Mahoney LT, Lauer RM. Increased carotid intimal-medial thickness and coronary calcification are related in young and middle-aged adults. The Muscatine study. Circulation 1999;100:838–842.Google Scholar
  51. 51.
    Geroulakos G, O'Gorman DJ, Kalodiki E, Sheridan DJ, Nicolaides AN. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J 1994;15:781–785.Google Scholar
  52. 52.
    Crouse JR III, Craven TE, Hagaman AP, Bond MG. Association of coronary disease with segment-specific intimalmedial thickening of the extracranial carotid artery. Circulation 1995;92:1141–1147.Google Scholar
  53. 53.
    Adams MR, Nakagomi A, Keech A, et al. Carotid intimamedia thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation 1995;92:2127–2134.Google Scholar
  54. 54.
    de Groot E, Jukema JW, van Boven AJ, et al. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: A report from the Regression Growth Evaluation Statin Study. Am J Cardiol 1995;76:40C–46C.Google Scholar
  55. 55.
    Visona A, Pesavento R, Lusiani L, et al. Intimal medial thickening of common carotid artery as indicator of coronary artery disease. Angiology 1996;47:61–66.Google Scholar
  56. 56.
    Hulthe J, Wikstrand J, Emanuelsson H, Wiklund O, de Feyter PJ, Wendelhag I. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke 1997;28:1189–1194.Google Scholar
  57. 57.
    Khoury Z, Schwartz R, Gottlieb S, Chenzbraun A, Stern S, Keren A. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol 1997;80:1429–1433.Google Scholar
  58. 58.
    Enderle MD, Schroeder S, Ossen R, et al. Comparison of peripheral endothelial dysfunction and intimal media thickness in patients with suspected coronary artery disease. Heart 1998;80:349–354.Google Scholar
  59. 59.
    Lekakis JP, Papamichael CM, Cimponeriu AT, et al. Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis. Am J Cardiol 2000;85:949–952.Google Scholar
  60. 60.
    Balbarini A, Buttitta F, Limbruno U, et al. Usefulness of carotid intima-media thickness measurement and peripheral B-mode ultrasound scan in the clinical screening of patients with coronary artery disease. Angiology 2000;51:269–279.Google Scholar
  61. 61.
    Mack WJ, LaBree L, Liu C, Selzer RH, Hodis HN. Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography. Atherosclerosis 2000;150:371–379.Google Scholar
  62. 62.
    Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483–494.Google Scholar
  63. 63.
    O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Reseach Group. N Engl J Med 1999;340:14–22.Google Scholar
  64. 64.
    Hodis HN, Mack WJ, LaBree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262–269.Google Scholar
  65. 65.
    Crouse JR III, Byington RP, Bond MG, et al. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLACII). Am J Cardiol 1995;75:455–459.Google Scholar
  66. 66.
    de Groot E, Jukema JW, Montauben van Swijndregt AD, et al. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: A report of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol 1998;31:1561–1567.Google Scholar
  67. 67.
    MacMahon S, Sharpe N, Gamble G, et al. Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: Results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group. Circulation 1998;97:1784–1790.Google Scholar
  68. 68.
    Hodis HN, Mack WJ, LaBree L, et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy. Ann Intern Med 1996;124:548–556.Google Scholar
  69. 69.
    Mercuri M, Bond G, Sirtori CR, et al. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: The carotid atherosclerosis Italian ultrasound study. Am J Med 1996;101:627–634.Google Scholar
  70. 70.
    Salonen R, Nyyssönen K, Porkkala E, et al. Kuopio Atherosclerosis Prevention Study (KAPS). A populationbased primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 1995;92:1758–1764.Google Scholar
  71. 71.
    Smilde TJ, vanWissen S, Wollersheim H, Trip MD, Kastelein JJP, Stalenhoef AFH. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): A prospective, randomised, double-blind trial. Lancet 2001;357:577–581.Google Scholar
  72. 72.
    Gotto AM Jr, Farmer JA. Pleiotropic effects of statins: Do they matter? Curr Opin Lipidol 2001;12:391–394.Google Scholar
  73. 73.
    Mack WJ, Selzer RH, Hodis H, et al. One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy. Stroke 1993;24:1779–1783.Google Scholar
  74. 74.
    Migdalis IN, Gerolimou B, Kozanidou G, Voudouris G, Hatzigakis SM, Petropoulos A. Effect of gemfibrozil on early carotid atherosclerosis in diabetic patients with hyperlipidaemia. Int Angiol 1997;16:258–261.Google Scholar
  75. 75.
    Wiklund O, Hulthe J, Wikstrand J, Schmidt C, Olofsson SO, Bondjers G. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: A 3-year randomized study. Stroke 2002;33:572-577.Google Scholar
  76. 76.
    Ahn CW, Lee HC, Park SW, et al. Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2001;52:45–53.Google Scholar
  77. 77.
    Lonn E, Yusuf S, Dzavik V, et al. Effects of ramipril and vitamin E on atherosclerosis: The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001;103:919–925.Google Scholar
  78. 78.
    de Kleijn MJJ, Bots ML, Bak AAA, et al. Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima-media thickness. Maturitas 1999;32:195–204.Google Scholar
  79. 79.
    Angerer P, Stork S, Kothny W, Schmitt P, von Schacky C. Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: A randomized, controlled trial. Arterioscler Thromb Vasc Biol 2001;21:262–268.Google Scholar
  80. 80.
    Hodis HN, Mack WJ, Lobo RA, et al. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;135:939–953.Google Scholar
  81. 81.
    Salonen JT, Nyyssonen K, Salonen R, et al. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: A randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 2000;248:377–386.Google Scholar
  82. 82.
    Greenland P, Abrams J, Aurigemma GP, et al. Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Noninvasive tests of atherosclerotic burden:Writing Group III. Circulation 2000;101:e16–e22.Google Scholar
  83. 83.
    Markwood TT, Kent SM, Coyle LC, Flaherty PJ, O'Malley PG, Taylor AJ. Design and rationale of the ARBITER trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)-A randomized trial comparing the effects of atorvastatin and pravastatin on carotid artery intima-media thickness. Am Heart J 2001;141:342–347.Google Scholar
  84. 84.
    Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998;19:1434–1503.Google Scholar
  85. 85.
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486–2497.Google Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Michiel L. Bots
    • 1
  • D. Egbertus Grobbee
    • 1
  1. 1.Julius Center for Health Sciences and Primary CareUniversity Medical Center UtrechtUtrechtThe Netherlands

Personalised recommendations